Long-Term Safety of NGX-4010, a High-Concentration Capsaicin Patch, in Patients with Peripheral Neuropathic Pain

David M. Simpson(Icahn School of Medicine at Mount Sinai), Geertrui F. Vanhove, Stephen Brown(AIDS Research Alliance), Shiao-Ping Lu, Suzanne Gazda(Integra (United States)), Jeffrey Tobias(Jazz Pharmaceuticals (United States)), Lynn R. Webster(Adherent Technologies (United States))
Journal of Pain and Symptom Management
June 1, 2010
10.1016/j.jpainsymman.2009.11.316
Cited by 107

Related Papers

The IASP classification of chronic pain for ICD-11: chronic neuropathic pain
|Pain|2018|1.1k
Predicting Aberrant Behaviors in Opioid-Treated Patients: Preliminary Validation of the Opioid Risk Tool
|Pain Medicine|2005|1.1k
Efficacy and Safety of Tifacogin (Recombinant Tissue Factor Pathway Inhibitor) in Severe Sepsis
|JAMA|2003|958
Risk Factors for Opioid-Use Disorder and Overdose
|Anesthesia & Analgesia|2017|504
Naloxegol for Opioid-Induced Constipation in Patients with Noncancer Pain
|New England Journal of Medicine|2014|331